Mozenavir (DMP-450) is an antiviral drug which was developed as a treatment for HIV/AIDS.

It acts as an HIV protease inhibitor and binds to this target with high affinity,[1][2] however despite promising results in early testing,[3][4] mozenavir was unsuccessful in human clinical trials.

Studies continue into related derivatives.

[5] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.